Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
phenotype | 0.400 | None | 0.989 | 24 | 0 | 2000 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
phenotype | 0.400 | None | 0.976 | 23 | 0 | 1994 | 2020 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
phenotype | 0.600 | None | 0.991 | 18 | 0 | 1996 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
phenotype | 0.600 | None | 0.970 | 17 | 0 | 1989 | 2020 | ||||||||
|
heparanase | 0.425 | 0.808 | 2.3E-14 |
|
phenotype | 0.400 | None | 0.972 | 15 | 0 | 1999 | 2020 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
phenotype | 0.400 | None | 0.960 | 15 | 0 | 1993 | 2020 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
phenotype | 0.600 | None | 0.983 | 15 | 0 | 1993 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.600 | None | 0.968 | 14 | 0 | 1998 | 2020 | ||||||||
|
vascular endothelial growth factor C | 0.459 | 0.769 | 0.50 |
|
phenotype | 0.100 | None | 0.970 | 14 | 0 | 1997 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
phenotype | 0.600 | None | 0.936 | 13 | 0 | 1991 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
phenotype | 0.400 | None | 0.995 | 11 | 0 | 2000 | 2020 | ||||||||
|
NME/NM23 nucleoside diphosphate kinase 1 | 0.443 | 0.808 | 3.2E-03 |
|
phenotype | 0.400 | None | 0.940 | 10 | 0 | 1989 | 2020 | ||||||||
|
vascular endothelial growth factor D | 0.538 | 0.769 | 2.5E-05 |
|
phenotype | 0.100 | None | 1.000 | 9 | 0 | 2000 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
phenotype | 0.400 | None | 0.973 | 9 | 0 | 1988 | 2020 | ||||||||
|
protein tyrosine phosphatase 4A3 | 0.566 | 0.654 | 4.5E-02 |
|
phenotype | 0.100 | None | 0.986 | 9 | 0 | 2001 | 2019 | ||||||||
|
insulin like growth factor 1 receptor | 0.399 | 0.885 | 0.97 |
|
phenotype | 0.100 | None | 0.966 | 8 | 0 | 1998 | 2019 | ||||||||
|
parathyroid hormone like hormone | 0.453 | 0.846 | 0.81 |
|
phenotype | 0.100 | None | 1.000 | 7 | 0 | 1992 | 2020 | ||||||||
|
matrix metallopeptidase 7 | 0.446 | 0.885 | 1.0E-09 |
|
phenotype | 0.100 | None | 0.987 | 7 | 0 | 1994 | 2019 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 7 | 0 | 2003 | 2018 | ||||||||
|
C-C motif chemokine receptor 7 | 0.443 | 0.769 | 5.8E-02 |
|
phenotype | 0.100 | None | 1.000 | 6 | 0 | 2003 | 2019 | ||||||||
|
CD82 molecule | 0.507 | 0.731 | 1.3E-08 |
|
phenotype | 0.600 | None | 0.973 | 6 | 0 | 1995 | 2019 | ||||||||
|
ezrin | 0.476 | 0.808 | 0.18 |
|
phenotype | 0.400 | None | 0.975 | 6 | 0 | 1999 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
phenotype | 0.400 | None | 0.962 | 6 | 0 | 1996 | 2020 | ||||||||
|
TIMP metallopeptidase inhibitor 1 | 0.380 | 0.885 | 0.50 |
|
phenotype | 0.100 | None | 1.000 | 5 | 0 | 1993 | 2020 | ||||||||
|
TNF superfamily member 11 | 0.453 | 0.846 | 4.9E-03 |
|
phenotype | 0.100 | None | 0.963 | 5 | 0 | 2003 | 2020 |